PT415 – Psychedelic Science 2023: The Largest Psychedelic Conference in History

Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic

PharmaTher Holdings Provides Corporate Update

Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical Officer

Wesana Health Announces Voting Results of AGSM

PT414 – Lena Franklin & Jeff Glattstein – The EAST Institute:...

Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by...

MIND CURE HEALTH INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF...

MIND CURE AND LNG ENERGY GROUP PROVIDE UPDATE ON PREVIOUSLY ANNOUNCED...

BetterLife Continues Progress on BETR-001 IND-Enabling Studies

Load more